Apellis Pharmaceuticals Inc
NASDAQ:APLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
Amerisafe Inc
NASDAQ:AMSF
|
US |
|
Home Depot Inc
NYSE:HD
|
US |
|
China National Nuclear Power Co Ltd
SSE:601985
|
CN |
|
Starbucks Corp
NASDAQ:SBUX
|
US |
Wall St Price Targets
APLS Price Targets Summary
Apellis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for APLS is 40.5166 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APLS's stock price target?
Price Target
40.5166
USD
According to Wall Street analysts, the average 1-year price target for APLS is 40.5166 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.
What is the Revenue forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Operating Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
38%
The compound annual growth rate for Operating Income over the next 8 years is 38%.
What is the Net Income forecast for Apellis Pharmaceuticals Inc?
Projected CAGR
49%
The compound annual growth rate for Net Income over the next 8 years is 49%.
